Capturing Synergies In Health System M&A: Are You Leaving Money On The Table?

Exhibit 1 Losing value

by Accenture
US hospitals have been consolidating with enthusiasm. Despite some pullback in 2014, deal volumes grew by 9 percent between 2010 and 2013. Bigger, however, does not automatically equate to better. Accenture research reveals that the synergies achieved from many of these deals have been disappointing. In fact, the average acquiring provider left nearly $25 million per target on the table in 2015: potential cost and revenue synergies that could have been invested in improving access and the total cost of care. […] Read more

Asia-Pacific Health Industries 2016: Keeping You Up-To-Date With The Latest Developments

Asia-Pacific Health Industries Newsletter 2016: Keeping You Up-To-Date With The Latest Developments

by PricewaterhouseCoopers
In recent years there has been a shift in the nature of healthcare, i.e., from reactive to preventative. An integral component of this shift has been the emergence of personalised medicine. Personalised medicine is a model that segments patients by risk of developing a specific disease, based on their genetic profile. This includes, molecular diagnosis and use of biomarkers to segment populations. […] Read more

Plotting A New Course: The Impact Of Brexit On M&A Activity

Figure 1 UK M&A volumes and values (H1 2005 - H1 2016)

by Deloitte
In the aftermath of the EU referendum vote, the reaction from currency and stock markets has been swift. It is clear that Brexit has shaken investor confidence. However, M&A markets are typically driven by longer term decision making processes. Brexit has created uncertainties and some M&A plans are being put on hold. But we think the post-Brexit tumult creates opportunities as well. In the coming months we expect there will be both threats to M&A dealmakers and unique opportunities for them. […] Read more

The Deloitte M&A Index – 2016: Opportunities Amidst Divergence

M&A Index – 2016: Opportunities Amidst Divergence

by Deloitte
We are expecting 2015 to end with over $4 trillion worth of deals making it the highest for deal values since 2007. However, on a last-twelve-months (LTM) basis, there was a slowdown in the volume of transactions in the second half of 2015. Cross-border deals are a major feature of this M&A wave. More than $1 trillion worth of cross-border deals have been announced so far this year, of which a third were in the vibrant deal corridor between North America and Europe. […] Read more

Asia-Pacific Health Industries 2015: Keeping You Up-To-Date With The Latest Developments

Asia-Pacific Health Industries Newsletter 2015

by PricewaterhouseCoopers
There is no other sector as important as health. Health matters to each of us as individuals. It is our most precious and valuable asset and connects us all like no other. Health also matters to society. It lies at the heart of our economic, political, social and environmental prosperity and is now the world’s largest industry – with a value and cost three times greater than the banking sector. […] Read more

M&A Trends In Life Sciences And Health Care: Growth At The Global Intersection Of Change

Figure 1 Drivers of M&A activity

by Deloitte
Anyone witnessing the feverish deal-making that has swept through the global life sciences and health care industry recently might well conclude that mergers-and-acquisitions (M&A) activity has become the dominant force shaping the industry. According to Thomson Reuters, the global year-to-date value of deals in the life sciences sector alone was $600bn for July 2014, compared with $200bn for the same period last year. […] Read more

The Coming Surge In Health Provider M&A: How Historical Forces And Healthcare Reform Will Combine To Drive Activity

The Coming Surge In Health Provider M&A: How Historical Forces And Healthcare Reform Will Combine To Drive Activity

by PricewaterhouseCoopers
Merger and acquisition activity among U.S. hospitals and integrated health providers increased in late 2010 after several slow years, and we expect it to expand significantly during the next several years — even if courts or legislators reverse some of the key provisions of the 2010 Affordable Care Act. Health systems will strive for scale and financial stability, and will seek to develop or acquire the capabilities they will need in order to undertake risk for clinical outcomes as they move toward population-based health accountability. […] Read more

Are you sure you
want to log out?

Request a Brochure

Request a Brochure

Contact us to discuss your goals and needs!

Contact us to discuss your goals and needs!

Book a Demo

Book a Demo

Contact us to discuss your goals and needs!

Contact us to discuss your goals and needs!